We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTX icon
3926
Context Therapeutics
CNTX
$55.1M
$44K ﹤0.01%
20,309
-44,309
-69% -$93.2K
TPHS
3927
DELISTED
Trinity Place Holdings Inc.com
TPHS
$44K ﹤0.01%
22,929
-11,451
-33% -$21.1K
CALC icon
3928
CalciMedica
CALC
$15.8M
$43K ﹤0.01%
2,524
+1,738
+221% +$33.1K
CREX icon
3929
Creative Realities
CREX
$41.1M
$43K ﹤0.01%
17,633
-38,251
-68% -$135K
IDN icon
3930
Intellicheck
IDN
$73.1M
$43K ﹤0.01%
+16,897
New +$61.6K
INM icon
3931
InMed Pharmaceuticals
INM
$7.85M
$43K ﹤0.01%
90
+2
+2% +$1.05K
SINT icon
3932
SiNtx Technologies
SINT
$10.8M
$42K ﹤0.01%
3
+1
+50% +$10.6K
RENO
3933
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$41K ﹤0.01%
+75,372
New +$41.5K
ADIL
3934
Adial Pharmaceuticals
ADIL
$7.31M
$40K ﹤0.01%
+32
New +$43.8K
LMFA
3935
DELISTED
LM Funding America
LMFA
$40K ﹤0.01%
+93
New +$47.8K
ONCY
3936
Oncolytics Biotech
ONCY
$89.9M
$40K ﹤0.01%
25,500
-209,978
-89% -$352K
RGLS
3937
DELISTED
Regulus Therapeutics
RGLS
$40K ﹤0.01%
13,340
+11,110
+498% +$28.9K
WDH
3938
Waterdrop
WDH
$402M
$40K ﹤0.01%
26,900
-369,182
-93% -$529K
XXII
3939
22nd Century Group
XXII
$1.38M
0
JSPR icon
3940
Jasper Therapeutics
JSPR
$21M
$39K ﹤0.01%
+1,087
New +$49K
SND icon
3941
Smart Sand
SND
$185M
$39K ﹤0.01%
11,400
-32,300
-74% -$85K
XTIA icon
3942
XTI Aerospace
XTIA
$57.3M
0
ITRM
3943
DELISTED
Iterum Therapeutics
ITRM
$38K ﹤0.01%
7,207
-1,273
-15% -$7.36K
NEPT
3944
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$38K ﹤0.01%
122
-199
-62% -$90.4K
KNDI
3945
Kandi Technologies Group
KNDI
$67.5M
$37K ﹤0.01%
+11,500
New +$36.6K
MATH icon
3946
Metalpha Technology Holding
MATH
$44.8M
$37K ﹤0.01%
36,500
+1,500
+4% +$1.69K
PHIO icon
3947
Phio Pharmaceuticals
PHIO
$11.8M
$37K ﹤0.01%
384
+290
+309% +$27.6K
TCRX icon
3948
TScan Therapeutics
TCRX
$48.6M
$37K ﹤0.01%
+13,300
New +$57.5K
EEIQ icon
3949
EpicQuest Education Group
EEIQ
$3.39M
$36K ﹤0.01%
1,019
-394
-28% -$15.5K
SIEB icon
3950
Siebert Financial
SIEB
$66.7M
$36K ﹤0.01%
16,800
-53,600
-76% -$115K

Similar funds

Renaissance Technologies's Q1 2022 Portfolio in Review

As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
  • Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
  • Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.